SUMMARY The prolonged effects (42 days) of indomethacin treatment on the renin-angiotensinaldosterone axis, renal hemodynamics, and renal excretory function in humans were studied. Indomethacin produced a 41% sustained depression in the 24-hour excretion of prostaglandin E 2 and a mild (7%) decrease in inulin clearance but did not affect the clearance of p-aminohippurate, the 24-hour excretion of sodium and potassium, or the basal values of plasma aldosterone; however, it decreased the basal values of renin and prevented the stimulated (3 hours of walking) responses of plasma renin activity and plasma aldosterone. Indomethacin also produced a decrease in both the diuretic and saluretic response to furosemide and in the renal ability to concentrate urine. The indomethacin-induced hyporeninism and hypoaldosteronism were more pronounced when the subjects were receiving a sodium-restricted diet. This finding indicates that prolonged administration of anti-inflammatory drugs induces chronic hyporeninism and hypoaldosteronism. Prolonged treatment with indomethacin also produced some of the symptoms of a syndrome of hypoprostaglandinism, such as decreased plasma renin activity, plasma aldosterone, and urinary prostaglandin E 2 in association with increases in plasma potassium levels and diastolic pressure. (Hypertension 8: 677-684, 1986) KEY WORDS * renin • aldosterone • prostaglandin E 2 • furosemide • degenerative joint disease * low sodium diet R ENAL prostaglandins play an important role in mediating the release of renin 1 2 and in regu-. lating renal function, as estimated through changes in renal blood flow, M glomerular filtration rate, 7 and renal handling of sodium and water. 8 Evidence also indicates that prostaglandins have a renal protective effect, especially in situations characterized by a decrease of renal perfusion.9 " 1 ' Under normal conditions, however, blockade of prostaglandin synthesis in association with the short-term administration of nonsteroidal anti-inflammatory drugs decreases renin release without inducing a marked impairment in renal From the Department of Nephrology (L.M. Ruilope, J.M. Alcazar, E. Miravalles, and J. Rodicio), Hospital "1° de Octubre," and the Department of Endocrinology